Alan Lotvin Biography and Net Worth

EVP of CVS Health

Alan Lotvin, M.D., is Executive Vice President, CVS Health, and President, CVS Caremark, the company’s pharmacy benefits management (PBM) business. In this role, Lotvin oversees all aspects of the PBM business including sales and account management, operations, mail service pharmacy, CVS Specialty, and CVS Kidney Care. Lotvin also drives PBM strategy, new business development and client relationship management and retention.

Prior to his current role, Lotvin served as executive vice president and chief transformation officer of CVS Health, and before that executive vice president of CVS Specialty, the specialty pharmacy of CVS Health.

Before joining CVS Health in 2012, Lotvin was president and chief executive officer of ICORE Healthcare, a Magellan Health Services company. Previously, Lotvin held multiple roles at Medco Health Solutions, including president of Medco Specialty Pharmacy Services and senior vice president of Manufacturer Contracting.

Lotvin holds US Patent #6269819 Method and Apparatus for Circulatory Valve Repair. He is co-author of the book Live Better, Live Longer.

Lotvin began his career as a practicing cardiologist in New Jersey. He holds a master's degree in Medical Informatics from Columbia University and a Medical Degree from the State University of New York Health Sciences Center in Brooklyn.

What is Alan Lotvin's net worth?: The estimated net worth of Alan Lotvin is at least $6.20 million as of August 4th, 2022. Dr. Lotvin owns 109,183 shares of CVS Health stock worth more than $6,204,870 as of November 21st. This net worth approximation does not reflect any other investments that Dr. Lotvin may own. Learn More about Alan Lotvin's net worth.
How do I contact Alan Lotvin?: The corporate mailing address for Dr. Lotvin and other CVS Health executives is ONE CVS DR., WOONSOCKET RI, 02895. CVS Health can also be reached via phone at (401) 765-1500 and via email at [email protected]. Learn More on Alan Lotvin's contact information.
Has Alan Lotvin been buying or selling shares of CVS Health?: Alan Lotvin has not been actively trading shares of CVS Health during the last quarter. Most recently, Alan Lotvin sold 22,541 shares of the business's stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $104.00, for a transaction totalling $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares of the company's stock, valued at $11,355,032. Learn More on Alan Lotvin's trading history.
Who are CVS Health's active insiders?: CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?: In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $53,880.00. In the last twelve months, insiders at the pharmacy operator sold shares 1 times. They sold a total of 29,473 shares worth more than $2,267,947.35. The most recent insider tranaction occured on May, 2nd when Director Edward J Ludwig bought 1,000 shares worth more than $53,880.00. Insiders at CVS Health own 0.2% of the company. Learn More about insider trades at CVS Health.
Information on this page was last updated on 5/2/2024.

Alan Lotvin Insider Trading History at CVS Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/4/2022	Sell	22,541	$104.00	$2,344,264.00	109,183
2/1/2022	Sell	21,386	$106.50	$2,277,609.00
6/28/2021	Sell	2,781	$83.67	$232,686.27	61,048
1/8/2021	Sell	25,836	$75.00	$1,937,700.00	18,469
11/13/2020	Sell	7,138	$70.00	$499,660.00	8,023
5/11/2020	Buy	5,000	$63.14	$315,700.00	15,161

Alan Lotvin Buying and Selling Activity at CVS Health

CVS Health Company Overview

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $56.83

$56.00

$57.67

50 Day Range

MA: $59.18

$53.19

$67.46

2 Week Range

Now: $56.83

$52.71

$83.25

Volume

11,334,702 shs

Average Volume

12,623,724 shs

Market Capitalization

$71.52 billion

P/E Ratio

14.42

Dividend Yield

4.77%

Beta

0.55

This company will win the AI race

From Porter & Company | Ad

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.